tirzepatide and hypoglycemia Exploring Hypoglycemic Ketoacidosis in Nondiabetic Patients on Tirzepatide: Is Starvation the Culprit? Tirzepatide for Weight Loss (Fat

An analysis of 26 studies (total 3020 patients) including 5 studies with psychiatric symptoms assessed as primary outcomes (for example, substance use disorders), and 21 studies with secondary outcomes, as well as an additional 10 registered clinical studies, was performed

All participants in the titrated insulin glargine treatment arm started with a baseline dose of 10 units per day and titrated following a treat-to-target algorithm to reach a fasting blood glucose below 100 mg/dL

oral GLP-1s Unlike small molecules, biological therapies such as GLP-1 analogs are administered via weekly subcutaneous or intravenous injections

Vitamin B12 has been shown to improve the depth and quality of sleep within studies

The earlier, the better